Routine screening for coxiella burnetii infection during pregnancy: A clustered randomised controlled trial during an outbreak, the Netherlands, 2010

Eurosurveillance

Volumn 18, Issue 24, 2013, Pages

  Munster, J M ^a   Leenders, A C ^b   Hamilton, C J ^b   Meekelenkamp, J C ^b   Schneeberger, P M ^b   van der Hoek, W ^c   Rietveld, A ^d   de Vries, E ^b   Stolk, R P ^a   Aarnoudse, J G ^a   Hak, E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b JEROEN BOSCH HOSPITAL   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d Municipal Health Service 'Hart voor Brabant'   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; ERYTHROMYCIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; COXIELLA BURNETII; EPIDEMIC; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MATERNAL SERUM SCREENING TEST; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PROSPECTIVE STUDY; Q FEVER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SERODIAGNOSIS; TREATMENT OUTCOME;

EID: 84879038550     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Schrag SJ, Arnold KE, Mohle-Boetani JC, Lynfield R, Zell ER, Stefonek K, et al. Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol. 2003;102(4):753-60. http://dx.doi.org/10.1016/S0029-7844(03)00671-9
2. European Centre for Disease Prevention and Control (ECDC). Annual epidemiological report on communicable diseases in Europe 2010. Stockholm: ECDC. 2010; Available from: http://www.ecdc.europa.eu/en/publications/Publications/1011_SUR_Annual_Epidemiological_Report_on_Communicable_Diseases_in_Europe.pdf
3. Schimmer B, Morroy G, Dijkstra F, Schneeberger PM, Weers-Pothoff G, Timen A, et al. Large ongoing Q fever outbreak in the south of The Netherlands, 2008. Euro Surveill. 2008;13(31):pii=18939. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18939
4. Parker NR, Barralet JH, Bell AM. Q fever. Lancet. 2006;367(9511):679-88. http://dx.doi.org/10.1016/S0140-6736(06)68266-4
5. Hartzell JD, Wood-Morris RN, Martinez LJ, Trotta RF. Q fever: epidemiology, diagnosis and treatment. Mayo Clin Proc. 2008;83(5):574-9.PMid:18452690.
6. Raoult D, Marrie TJ, Mege JL. Natural history and pathophysiology of Q fever. Lancet Infect Dis. 2005;5(4):219-26. http://dx.doi.org/10.1016/S1473-3099(05)70052-9
7. Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A. Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clin Infect Dis. 2007;45(5):548-55. http://dx.doi.org/10.1086/520661. PMid:17682987.
8. Langley JM, Marrie TJ, Le Blanc JC, Almudevar A, Resch L, Raoult D. Coxiella burnetii seropositivity in parturient women is associated with adverse pregnancy outcomes. Am J Obstet Gynecol. 2003;189(1):228-32. http://dx.doi.org/10.1067/mob.2003.448. PMid:12861167.
9. Tissot-Dupont H, Vaillant V, Rey S, Raoult D. Role of sex, age, previous valve lesion and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis. 2007;44(2):232-7. http://dx.doi.org/10.1086/510389. PMid:17173223.
10. Roest HI, Tilburg JJ, Van der Hoek W, Vellema P, van Zijderveld FG, Klaassen CH, et al. The Q fever epidemic in The Netherlands: history, onset, response and reflection. Epidemiol Infect 2011;139(1):1-12. http://dx.doi.org/10.1017/S0950268810002268. PMid:20920383.
11. National Institute for Public Health and the Environment. Gemelde Q-koortspatiënten 2007-2011. [Notified number of Q fever cases 2007-2011, incidence per municipality]. Bilthoven: RIVM; [Accessed Jun 2013]. Available from: http://www.rivm.nl/dsresource?objectid=rivmp:180268&type=org&disposition=inline&ns_nc=1
12. Van der Hoek W, Meekelenkamp JC, Dijkstra F, Notermans DW, Bom B, Vellema P, et al. Proximity to goat farms and Coxiella burnetii seroprevalence among pregnant women. Emerg Infect Dis. 2011;17(12):2360-3. http://dx.doi.org/10.3201/eid1712.110738. PMid:22172140. PMCid:3311170.
13. Statistics Netherlands. No home internet access for 1.2 million Dutch people. Den Haag: Statistics Netherlands. 18 Dec 2008; Available from: http://www.cbs.nl/en-GB/menu/themas/vrije-tijd-cultuur/publicaties/artikelen/archief/2008/2008-2641-wm.htm?Languageswitch=on
14. Meekelenkamp JC, Schneeberger PM, Wever PC, Leenders AC. Comparison of ELISA and indirect immunofluorescent antibody assay detecting Coxiella burnetii IgM phase II for the diagnosis of acute Q fever. Eur J Clin Microbiol Infect Dis. 2012;31(6):1267-70. http://dx.doi.org/10.1007/s10096-011-1438-0. PMid:21997772.
15. Wegdam-Blans MC, Kampschreur LM, Delsing CE, Bleeker-Rovers CP, Sprong T, van Kasteren ME, et al. Chronic Q fever: review of the literature and a proposal of new diagnostic criteria. J Infect. 2012;64(3):247-59. http://dx.doi.org/10.1016/j.jinf.2011.12.014. PMid:22226692.
16. Visser GH, Eilers PH, Elferink-Stinkens PM, Merkus HW, Wit JM. New Dutch reference curves for birthweight by gestational age. Early Hum Dev. 2009;85(12):737-44. http://dx.doi.org/10.1016/j.earlhumdev.2009.09.008. PMid:19914013.
17. Alberts M, Smets EMA, Vercoulen JHMM, Garssen B, Bleijenberg G. Verkorte vermoeidheidsvragenlijst: een praktisch hulpmiddel bij het scoren van vermoeidheid. [Shortened fatigue questionnaire: a practical aid in scoring fatigue]. Ned Tijdschr Geneeskd. 1997;141(31):1526-30. Dutch. PMid:9543741.
18. Centre for Health Economics, University of York. The EuroQoL Group. EuroQol: A new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199-208. http://dx.doi.org/10.1016/0168-8510(90)90421-9.
19. Karagiannis I, Schimmer B, Van Lier A, Timen A, Schneeberger P, Van Rotterdam B, et al. Investigation of a Q fever outbreak in a rural area of the Netherlands. Epidemiol Infect 2009;137(9):1283-94. http://dx.doi.org/10.1017/S0950268808001908. PMid:19161644.
20. Meekelenkamp JCE, Notermans DW, Rietveld A, Marcelis JH, Schimmer B, Reimerink JHJ, et al. Seroprevalence of Coxiella burnetii in pregnant women in the province of Noord-Brabant in 2007. Infectieziekten Bulletin. 2009;20(2):57-61. Dutch.
21. Melville J, Sniffen S, Crosby R, Salazar L, Whittington W, Dithmer-Schreck D, et al. Psychosocial impact of serological diagnosis of herpes simplex virus type 2: a qualitative assessment. Sex Transm Infect. 2003;79(4):280-5. http://dx.doi.org/10.1136/sti.79.4.280. PMid:12902574. PMCid:1744709.
22. Breteler JK, Oudhoff JP, Munster JM, Aarnoudse JG, van Steenbergen JE, Beaujean DJ. Risks, trust and knowledge: determinants of pregnant women's decisions regarding participation in a future Q fever screening and treatment program during a large epidemic in The Netherlands. Prenat Diagn. 2011;31(8):814-20. http://dx.doi.org/10.1002/pd.2772. PMid:21717482.
23. Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med. 2000;343(22):1608-14. http://dx.doi.org/10.1056/NEJM200011303432204. PMid:11096168.
24. Nielsen SY, Hjøllund NH, Andersen AM, Henriksen TB, Kantsø B, Krogfelt KA, et al. Presence of antibodies against Coxiella burnetii and risk of spontaneous abortion: a nested case-control study. PLoS One. 2012;7(2):e31909. http://dx.doi.org/10.1371/journal.pone.0031909. PMid:22363769. PMCid:3283715.
25. Ravelli AC, Jager KJ, de Groot MH, Erwich JJ, Rijninks-van Driel GC, Tromp M, et al. Travel time from home to hospital and adverse perinatal outcomes in women at term in the Netherlands. BJOG 2011;118(4):457-65. http://dx.doi.org/10.1111/j.1471-0528.2010.02816.x. PMid:21138515.
26. Tromp M, Eskes M, Reitsma JB, Erwich JJ, Brouwers HA, Rijninks-van Driel GC, et al. Regional perinatal mortality differences in the Netherlands; care is the question. BMC Public Health. 2009;9:102. http://dx.doi.org/10.1186/1471-2458-9-102. PMid:19366460. PMCid:2674436.
27. Van der Hoek W, Meekelenkamp JCE, Leenders ACAP, Wijers N, Notermans DW, Hukkelhoven CW. Antibodies against Coxiella burnetii and pregnancy outcome during the 2007-2008 Q fever outbreaks in the Netherlands. BMC Infect Dis. 2011;11:44. http://dx.doi.org/10.1186/1471-2334-11-44. PMid:21314933. PMCid:3042933.
28. De Carolis S, Santucci S, Botta A, Garofalo S, Martino C, Perrelli A, et al. False-positive IgM for CMV in pregnant women with autoimmune disease: a novel prognostic factor for poor pregnancy outcome. Lupus 2010;19(7):844-9. http://dx.doi.org/10.1177/0961203310361350. PMid:20305050.
29. Jones JL, Krueger A, Schulkin J, Schantz PM. Toxoplasmosis prevention and testing in pregnancy, survey of obstetrician-gynaecologists. Zoonoses Public Health. 2010;57(1):27-33. http://dx.doi.org/10.1111/j.1863-2378.2009.01277.x. PMid:19744302.
30. Stein A, Raoult D. Q fever during pregnancy: a public health problem in Southern France. Clin Infect Dis. 1998;27(3):592-6. http://dx.doi.org/10.1086/514698
31. Huijsmans CJ, Schellekens JJ, Wever PC, Toman R, Savelkoul PH, Janse I, et al. SNP-genotyping of a Coxiella burnetii outbreak in the Netherlands. Appl Environ Microbiol. 2011;77(6):2051-7. http://dx.doi.org/10.1128/AEM.02293-10. PMid:21257816. PMCid:3067327.
32. Wever PC, Arts CH, Groot CA, Lestrade PJ, Koning OH, Renders NH. Screening for chronic Q fever in symptomatic patients with an aortic aneurysm or prosthesis. Ned Tijdschr Geneeskd. 2010;154:A2122. Dutch. PMid:20699030.
33. Angelakis E, Million M, D'Amato F, Rouli L, Richet H, Stein A, et al. Q fever and pregnacy: disease, prevention, and strain specificity. Eur J Clin Microbiol Infect Dis. 2013;32(3):361-8. http://dx.doi.org/10.1007/s10096-012-1750-3. PMid:23052984.
34. Rey D, Obadia Y, Tissot-Dupont H, Raoult D. Seroprevalence of antibodies to Coxiella burnetii among pregnant women in South Eastern France. Eur J Obstet Gynecol Reprod Biol. 2000;93(2):151-6. http://dx.doi.org/10.1016/S0301-2115(00)00276-1